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Gene therapy is an emerging field in medical and
pharmaceutical sciences. However, naked therapeutic
genes are rapidly degraded by nucleases, showing poor
and non-specific cellular uptake and low transfection
efficiency.[1] Therefore the development of a safe
and efficient gene carrier is primordial for the success
of gene therapy. Systems based on chitosan macro-
molecular micelles, commonly called nanogels, are now
extensively used in drug delivery; they form stable
complexes with nucleic acids, protect them fromnuclease degradation, interact readily with cellular
membrane, and show pH buffering capacity, which is
critical for endosomal escape and subsequent gene
silencing efficiency, although less efficiently than poly
(ethylene imine).[2]
Chitosan is obtained from chitin—amain component of
the exoskeleton of insects, crustaceous and cell walls
of fungi—by deacetylation. This linear polysaccharide
is composed of glucosamine and N-acetylglucosamine
units linked through glycosidic bonds.[3] It gathers a
number of desirable characteristics such as: cationic
charge, biodegradability, biocompatibility, low toxicity,
muco-adhesiveness, and reactive sites for chemical
modifications.[2,4] However, its poor solubility at physio-
logical and basic pH (pKa values range from 6.2 to 7),
has limited its effective utilization.[5] Among water-
soluble chitosan derivatives chitosan nanogel (GC) has
emerged as novel gene carrier due to its solubility at
physiological pHprovidedbyethyleneoxideunits, besides
its proved biocompatibility in vivo.[6,7] Its positive charge
under slightly acidic conditions allows the electrostatic
interaction between GC and negatively charged siRNA.DOI: 10.1002/mabi.201300123 1369
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1370The siRNA loading depends among other parameters on
the N/P ratio, defined as themolar ratio of chitosan amino
groups tonucleic acid phosphate groups. HigherN/P ratios
have been required to complex siRNA efficiently and
achieve the greatest level of silencing.[4] Under neutral or
alkaline conditions the binding is stabilized essentially
by hydrogen bonding and hydrophobic interactions.[8]
Successful transfection efficiency is also related to a
specific cellularuptake. In this study, folatewas selected as
model targeting molecule because folate receptors are
overexpressed in a wide range of tumors and rarely found
in normal cells.[9] Folate was conjugated to GC using a
PEG linker. Since Chan et al.[10] verified that folate grafting
slightly decreases the solubility, we added an extra
amount of PEG to overcome this issue. PEGlyation – in
addition to improving the solubility – also reduces the
opsonin adsorption and subsequent scavenging by
the mononuclear phagocyte system, enhancing the
longevity of a nanogel in blood.[11]
The aim of present study was to develop GC based
nanogel through chemical grafting of hydrophobic chains
on the hydrophilic backbone, resulting in an amphiphilic
polymer capable of self-assembling in aqueous environ-
ment. The targeting ability was assessed using folate as
a ligand. The ability of GC nanogel to complex siRNA
was evaluated to explore their potential as an siRNA
delivery system. Cell viability and the response of macro-
phages to nanogel were also investigated. The results
showed that GC nanogel is a promising carrier for targeted
gene delivery.2. Experimental Section
2.1. Materials
Culture medium reagents were purchased from Biochrom. GC
(G7753), mercapto hexadecanoic acid (MHDA), folate, N-hydroxy-
sulfosuccinimide (NHS), 1-ethyl-3-[3-dimethylaminopropyl]carbo-
diimide hydrochloride (EDC), O-methyl-O0-succinylpolyethyene
glycol 2000 (PEG2000), O-(2-aminoethyl)-O0-(2-carboxyethyl)poly-
ethylene glycol 3000 hydrochloride (PEG3000) were acquired from
Sigma–Aldrich. 5/6-Carboxyfluorescein succinimidyl ester was
purchased from Thermo Scientific.2.2. GC Analysis
2.2.1. 1H Nuclear Magnetic Resonance (1H NMR)
Spectroscopy Analysis
The 1H NMR spectra were obtained using a Varian Unity Plus 300
spectrometer operating at 299.94MHz and 70 8C. The GC solution
sample was prepared at 10mgmL1 in 2% DCl/D2O. 0.05wt% 3-
(trimethylsilyl)propionic-2,2,3,3-d4 acid (TSP) was used as a
quantification reference for all chemical shifts.Macromol. Biosci. 201
 2013 WILEY-VCH Verlag GmbH2.2.2. Refractive-Index Increment (dn/dc)
dn/dc was evaluated using a differential refractometer
operating at l¼658 nm (Optilab rEX). Six solutions (a parent
solution and five dilutions) were analyzed to determine each
value of dn/dc.
2.2.3. Gel-Permeation Chromatography
Size-exclusion chromatography (SEC) was coupled online with a
multiangle laser light scattering (MALLS) detector. SEC was
performed by means of an IsoChrom LC pump (Spectra Physics)
connected to TSK gel 2500PW and TSK gel 6000PW columns. An
Optilab rEX differential refractometer and a multiangle laser-light
scattering detector, operating at 690nm (Wyatt Dawn EOS) and 18
angles, were connected online. A 0.15M ammonium acetate/0.2M
acetic acid buffer (pH4.5)was used as the eluent. The flow ratewas
0.5mLmin1. The polymer solutions were prepared by dissolving
1mg of polymer in 1mL of buffer solution, then filtered on a
0.45mm pore size membrane (Millipore) before the injection of
50mL of solution.2.3. Self-Assembled Nanogel Synthesis
2.3.1. Preparation of GC Nanogel
GC nanogel was prepared by chemical conjugation of MHDA
to GC, through carbodiimide chemistry, as depicted in
Scheme 1A.[12,13] In detail, GC (200mg) was dissolved in 24mL of
distilled water at 50 8C for 2 h, under magnetic stirring. Then the
GC solution was diluted in methanol 1:3 v/v (water/methanol).
After homogenization, MHDA was added according to the
desirable degree of substitution (DS) and left dissolving for 3 h.
EDC and NHS were then mixed (both in 1.5-fold molar excess
with regard to MHDA) to activate the MHDA. The reaction was
performed for 24h at 50 8C under magnetic stirring. The reaction
product was extensively dialysed (molecular weight cutoff
(MWCO)¼ 10–12kDa) against distilled water, followed by freeze-
drying. The lyophilized GC nanogel, a blank fluffy product, was
stored at room temperature.
2.3.2. Functionalization of GC Nanogel with Folate
(GCFA Nanogel)
The functionalization of nanogelwith folate occurred in two steps.
In thefirst step, folatewas conjugated to PEG3000 (FA-PEG3000), as
described by Zheng et al.[14]; then, in the second step, FA-PEG3000,
PEG2000, and MHDA were grafted on the GC polymer. In brief,
folate was activated by reacting with EDC and NHS (using 10 and
1.2-fold molar excesses, respectively) in anhydrous DMSO, for 3 h.
Then, 2-mercaptoethanol (tenfold molar excess to EDC) was added
to quench the unreacted EDC. The reactive folate solution was
joined by adding it dropwise to PEG3000 dissolved in anhydrous
DMSO, under stirring. The reactionwas conducted for 18h, at room
temperature, in the dark. The resulting mixture was dialysed
(MWCO¼1 kDa) first against DMSO, to remove unbounded folate
and then with distilled water. The dialyzed product was freeze-
dried. The second step consisted of the same reaction as described3, 13, 1369–1378
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Scheme 1. Representation of A) GC and B) GCFA nanogels synthesis.
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addition to MHDA, FA-PEG3000 and PEG2000 were also added to
the reaction mixture, as shown in Scheme 1B. The lyophilized
GCFA nanogel had a yellowish tonality; it was stored at room
temperature, protected from light.
2.3.3. Nanogel Self-Assembly
The lyophilized samples were dispersed in distilled water under
magnetic stirring at 50 8C. After 48h, the nanogel solution was
filtered using a membrane with a pore size of 0.45mm and stored
at 4 8C.2.4. Nanogel Characterization
2.4.1. 1H NMR Spectroscopy Analysis
The MHDA substitution degree was quantified by preparing a
nanogel dispersion with a concentration of 7mgmL1 in 2% v/v
DCl/D2O followedby the acquisition of
1HNMRspectra on aVarian
Unity Plus 300 spectrometer operating at 299.94MHz at 70 8C.
2.4.2. Dynamic Light Scattering (DLS)
The size distribution, mean hydrodynamic diameter, and surface
charge of the nanogels were evaluated using a Malvern ZetasizerMacromol. Biosci. 20
 2013 WILEY-VCH Verlag Gmwww.MaterialsViews.comNANO ZS (Malvern Instruments Limited, UK). The nanogel
dispersions (1mgmL1 in distilled water, prepared as described
above)were analyzed at 25 8C in a polystyrene cell using a detector
angle of 1738.
2.4.3. Cryo-Field-Emission Scanning Electron Microscopy
(Cryo-FESEM)
TheGCnanogel (1mgmL1 indistilledwater)was frozenat200 8C
with liquid nitrogen and transferred to the cryo stage (Gatan, Alto
2500, UK) of an electron microscope (SEM/EDS: FESEM JEOL
JSM6301F/Oxford Inca Energy 350). Each sample was fractured
with a knife, and sublimated for 10min at95 8C to remove an ice
layer, allowing thenanogels to be exposed. At140 8C, the samples
were sputter-coatedwithgoldandpalladiumusinganaccelerating
voltage of 10 kV. The samples observationwas done at140 8Cand
15kV.
2.4.4. Fluorescence Spectroscopy
The critical aggregation concentration (CAC) of the GC and GCFA
nanogelsweredeterminedmeasuring thefluorescence intensityof
a hydrophobic probe Nile Red (NR) loaded onto the core of the
nanogel. Lyophilized nanogelwas dispersed inwater at 1mgmL1,
as above-mentioned. Then, nanogel suspension was diluted to a
range of concentrations from 1 to 0.001mgmL1 in 1mL of final
volume. Then, 5mL of an NR solution with a concentration of13, 13, 1369–1378
bH & Co. KGaA, Weinheim 1371
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13724 105 M in ethanol was added to each tube, yielding an NR final
concentration of 2107 M and 0.5% of ethanol. The nanogel
solutions containing NR were left overnight in a turning wheel to
keep the solution agitated, at room temperature. The solutions
were then analyzed using a Spex Fluorolog 3 spectrofluorimeter,
with excitatoin at 550nm and recording the emission in the range
from 560 to 760nm.2.5. Cell Culture
2.5.1. HeLa Cell Line
HeLa cells (HeLa T-REx, from Invitrogen) were maintained at 37 8C
in a humidified air containing 5%CO2 in RPMI-1640 supplemented
with 10% heat-inactivated fetal bovine serum (FBS), 100 IU mL1
penicillin and 0.1mgmL1 streptomycin.
2.5.2. Mouse Leukemic Monocyte Macrophage (RAW) Cell
Line
The RAW cell line RAW 264.7 (ATCC TIB-71) was maintained in
Dulbecco’s modified Eagle medium (DMEM) supplemented with
10% FBS and 100 IUmL1 penicillin and 0.1mgmL1 streptomycin.
The cells were incubated at 37 8C in a humidified air containing
5% CO2.
2.5.3. Murine Bone-Marrow-Derived Macrophages
(BMDM)
Procedures involving mice were performed according to the
European Convention for the Protection of Vertebrate Animals
used for Experimental and Other Scientific Purposes (ETS 123) and
86/609/EEC Directive and Portuguese rules (DL 129/92). Macro-
phages were collected from femoral and tibial mouse bone
marrow. Mouse long bones were extracted from the mouse
under aseptic conditions and flushed with RPMI-1640. The
resulting cell suspension was centrifuged at 500g during 10min.
The cell pellet was resuspended in RPMI-1640 supplemented with
10mM HEPES, 10% heat-inactivated FBS, 60mgmL1 penicillin/
streptavidin, 0.005mM b-mercaptoethanol (RPMI complete medi-
um), and 10% L929 cell conditioned medium (LCCM). To remove
adherent bone marrow cells, the cell suspension was incubated
overnight at 37 8C and 5% CO2 atmosphere in a Petri dish. The non-
adherent cells were collected, centrifuged at 500g (10min)
and seeded in 24-well plates at 5105 cells per well in RPMI
complete medium containing 10% of LCCM and incubated at 37 8C
in a 5% CO2 atmosphere. Four days after seeding 10% of LCCM
was re-added to the cultures. The culture medium was replaced
with fresh RPMI completemediumcontaining 10% LCCMonDay7.
After 10 d in culture, cells were completely differentiated into
macrophages.[15,16]2.6. In Vitro Cell Cytotoxicity Studies
Cells were seeded in 96-well plates at a density of 2500 per well
for HeLa and 5000 for RAW cell lines, and left adhering in 0.2mL
of culture medium overnight. The medium was replaced byMacromol. Biosci. 201
 2013 WILEY-VCH Verlag GmbHnanogel dispersions in culture medium containing 25% of water
v/v. After 24, 48, and 72 h the cellular viability was determined
using theMTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide)[17] quantitative colorimetric assay. The tetrazoli-
um salt is reduced by metabolically active cells using mitochon-
drial succinate dehydrogenase enzymes. The resulting dark blue
formazan crystals could be solubilized in dimethyl sulfoxide and
quantified spectrophotometrically at 570 nm, subtracting the
background optical density (690 nm). The test was performed in
triplicate.2.7. Cellular Uptake
2.7.1. Preparation of NHS-Fluorescein Nanogel
The production of GC and GCFA nanogels labeled with NHS-
fluorescein was achieved by grafting the fluorophore agent
through an amide linkage, as described ahead. The NHS-
fluorescein was dissolved in DMSO, at a concentration of 1%.
The molar ratio of NHS-fluorescein carboxylic groups to the GC
and GCFA nanogels free amine groups was 0.25. The dye was
added to a stirred nanogel suspension at a concentration of
1mgmL1 in PBS. The reaction was allowed to occur overnight
at room temperature, in the dark. The reaction mixture was
thoroughly dialysed (MW cutoff 10–12 kDa) against distilled
water to remove free NHS-fluorescein. As to verifying the absence
of free dye, the final solution of nanogel-fluorescein was purified
by centrifugation through a 10 kDa MWCO filter.
2.7.2. Confocal Laser Scanning Microscopy
HeLa cells and BMDMwere seeded at a density of 5 105 cells per
well in a 24-well plate (with a coverslip in each well), and left
adhering overnight. The cells were incubated with 0.2mgmL1 of
each nanogel-fluorescein suspension in culture medium contain-
ing 25% of water v/v. After 6 h, the coverslips were washed twice
with PBS at room temperature and the cells were fixed with
paraformaldehyde 2% for 25min. After washing the cells twice
with PBS twice, 40 ,6-diamidino-2-phenylindole (DAPI) (120ng
mL1)wasused to stain thenucleus for 3minat roomtemperature.
After washing, the preparations were observed in a confocal laser
scanning microscope Leica SP2 AOBS SE (Leica Mycrosystems,
Germany).2.8. siRNA–Nanogel Interaction
The siRNA binding ability of the nanogel was tested by gel
retardation assay. Suspensions of the nanogel in buffer solution
at pH 4.5 were mixed with siRNA (1mg) under three different
molar ratios of amine to phosphate groups, and gently vortexed.
The formulations nanogel/siRNA were incubated for 30min
at room temperature prior to loading into a 4% agarose gel
electrophoresis to allow the formation of the nanogel/siRNA
complexes. The electrophoresis was carried out at 100V for
30min in Tris–acetate–EDTA buffer (40mM Tris–HCl, 1% v/v
acetic acid, 1mM EDTA). SYBR safe was used to visualize siRNA
using a UV transilluminator at 365 nm.3, 13, 1369–1378
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Table 1. SEC-MALLS characterization of GC using a value of dn/
dc¼0.153mLg1.
Mn
[g mol1]
Mw
[g mol1]
Mz
[g mol1] Mw=Mn
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www.mbs-journal.de2.9. Statistical Analysis
Data were expressed as mean stand. deviation. All the statistics
to cell viability resultswere performed applying two-way analysis
of variance (ANOVA) tests through Prism software (GraphPad
software version 5.00, USA). Differences were considered signifi-
cant when p<0.05.
67 000 5% 100 000 3% 167 000 13% 1.509 6%3. Results and Discussion
3.1. GC Characterization
The GC used for nanogel synthesis was purchased from
Sigma–Aldrich. A comprehensive characterization of this
material is not available in the product data sheet and the
characterization found inthe literature isnot consistent.[18–
22] Therefore, the degree of deacetylation and themolecular
weights of the polymer were analyzed by 1H NMR
spectroscopy and SEC.
Figure 1 shows the 1H NMR spectrum of GC dissolved in
2% v/v DCl/D2O, obtained at 70 8C. The characterization of
GC by 1H NMR spectroscopy has been extensively used,
since it allows the straightforward assignment of the GC
proton peaks[22] and thereby the determination of the
degree of deacetylation.[23] The 1H NMR spectroscopy
measurements at 70 8C cause the shift of the solvent
proton peak from 4.8 ppm to 4.3, allowing the H-1 peak to
become visible. A GC degree of deacetylation of 88% was
calculated according to the approach described by Lavertu
et al.,[23] using the integral intensity of the proton H1 of
deacetylated monomer (H1-D) and the three protons of
methyl group (—CH3). The degree of deacetylationwas also
determined according to Hirai et al.[24] equation and a
similar value was achieved.
The SEC-MALLS GC mass determination, namely the
number, weight and Z-average molecular weight (Mn,Mw,Figure 1. Three-hundred megahertz 1H NMR spectrum of GC in 2% v/v
(A) and schematic representation of GC monomer acetylated (B) and
Macromol. Biosci. 20
 2013 WILEY-VCH Verlag Gmwww.MaterialsViews.comandMz, respectively) andpolydispersity index (Mw=Mn) are
described in Table 1.
The values of Mn (67 kDa) and Mw (100 kDa) obtained
are not in agreement with those reported by Knight
et al.[22] 178 and 237 kDa, respectively, although GC from
Sigma was used also in that case. Also using the
same source, Park et al.[21] reported a Mw of 250 kDa.
Also regarding the GC degree of acetylation some
inconsistency is noted comparing the values obtained
in this work with those reported in the literature:
Dufes et al.[19] obtained a value of 33% and Park et al.[21]
17.3%. It is not clear whether the different samples
described in the literature correspond to different
batches of glycol chitosan or whether the different
properties reported arise from technical issues. Neverthe-
less, the properties of GC used for the development
of biomedical materials must be well-characterized in
order to make possible a proper comparison of data
obtained in different labs.3.2. Synthesis and Physicochemical Characterization
of Nanogels
The covalent attachment of hydrophobic chains on the
hydrophilic GC backbone results in the generation of
amphiphilic material, which self-assembles in water. TheDCl/D2O at 70 8C
deacetylated (C).
13, 13, 1369–1378
bH & Co. KGaA, Weindecoration of the nanogel with FA-
PEG3000 and PEG2000was alsomediated
bya crosslinking reaction. Thepresenceof
MHDA, PEG, and folate on the polysac-
charide were confirmed by 1H NMR
spectroscopy. The MHDA DS was calcu-
lated from the following equation:heimDSMHDA ¼ 12a
26b  100 ð1Þwhere a represents the integral of MHDA
—CH2—protons signal detected between
1.2 and 1.6 ppm (which does not include
the —CH2— protons signals next to
the carbonyl and thiol groups) and b the
integral ofGCprotonpeaksobserved from
3 to 4.2 ppm, (Figure 2A). The DS obtained1373
Figure 2. 1H NMR spectra of A) GC nanogel and B) GCFA in 2% v/v DCl/D2O at 70 8C.
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1374was about 9%, that is, 9 out of 100 sugar residues are
substitutedwith the alkane chain. Given the theoretical DS,
15%, the reaction efficiency is about 60%. The yield reaction
was reproducible for all batches.
The successful conjugation of FA-PEG3000 and PEG2000
on GC was confirmed by the presence of characteristic
peaks between 6 and 9ppm assigned to aromatic protons
of folic acid and at 3.7 ppm (—CH2CH2O—) for PEG
protons (Figure 2B).[14] Nonetheless, it has not been
possible to determine the corresponding DS due to over-
lapping of the proton signal derived from PEG andFigure 3. A) Size distribution by intensity, zeta potential and B) Cryo-FESEMmicrograph
of GC nanogel (scale bar: 2mm); C) size distribution by intensity and zeta potential of
GCFA nanogel; D) colloidal stability of nanogels evaluated by average hydrodynamic
diameter of GC (*) and GCFA (&) nanogels overtime. Both nanogel samples were
prepared in distilled water and stored at 4 8C. The measurements were performed at
25 8C.sugar residues. Since these molecules
are grafted through a similar reaction
used for MHDA, it may be speculated
that the reaction yield might have been
similar. Based on this assumption, the
FA-PEG3000 and PEG2000 DS would
correspond to 6 and 12%, respectively.
PEG was used to improve the folate
water-solubility, also performing as a
spacer and enabling an efficient binding
to the folate receptor.[14,25]
Self-assembled nanogels give rise to
a unimodal particle size distributions,
between 100 and 400nm for the GC
nanogel (Figure 3A), with an average
size of 250nm, and between 60 and
500nm for GCFA (Figure 3C) with
200nm as mean diameter. The function-
alized nanogel population was slightly
more polydisperse than GC nanogel, with
polydispersity indexes of 0.4 and 0.3,
respectively. The surface charge of the
nanogels in aqueous solution was posi-
tive (potential zeta of about 25–30mV)
due to presence of protonated amine
groups. As expected, the GCFA nanogelMacromol. Biosci. 201
 2013 WILEY-VCH Verlag GmbHsurface charge was less positive, because fewer free amine
groups are available. The nanogel morphology under cryo-
FESEM was spherical as shown in Figure 3B, and the size
distribution observed confirm the results obtained by
dynamic light scattering (DLS). Cryo-FESEM allows the
observation of the nanogel close to its natural liquid state,
preserving the three dimensional structure[26] The stability
of the nanogels in aqueous solution was studied over time
by DLS. As observed in Figure 3D, both nanogels are stable
for at least four months, which represents a high colloidal
stability.3, 13, 1369–1378
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Figure 4. Emission spectra of Nile red (2 107 M) as function of A) GC and B) GCFA nanogel concentration in mg/mL (lex¼ 550nm); Plot of
fluorescence intensity (*) and maximum emission wavelength (&) of NR versus C) GC or D) GCFA nanogel concentration.
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www.mbs-journal.deSelf-aggregation behavior of GC and GCFA nanogels was
studied using Nile Red (NR) as a hydrophobic fluorescent
probe, whose absorbance and emission maxima shift to
higher wavelengths with increasing polarity of the probe
environment.[27,28] The fluorescence emission spectra of
NR as function of the nanogel concentration are shown in
Figure 4A and B, respectively. At low concentrations, in
aqueous solution, the emission is close to the background
intensity. However, the intensity increases abruptly above
a certain nanogel concentration, indicating the formation
of hydrophobic regions able to dissolve the NR probe.
Associated with the increased fluorescence intensity, a
shift of the emission maxima towards lower wavelengths
was observed with the increase of the nanogel concentra-
tion, due to the lower polarity surrounding the probe
hydrophobic cores of the nanogels.[29] This transitional
concentration is commonly named CAC, the minimal
concentration required for the amphiphilic polysaccharide
conjugates (Figure 4D) to self-assemble forming a nanogel.Macromol. Biosci. 20
 2013 WILEY-VCH Verlag Gmwww.MaterialsViews.comThe CAC value of the GC nanogel was 0.1mgmL1
(Figure 4C). Values in the same order of magnitude have
been reported by ref.[30] for fluorescent chitosan nano-
particles (0.06mgmL1) and by ref.[31] (0.123mgmL1) for
cholesterol modified GC. The modification of the nanogel
with PEG, besides conferring increased solubility, also
enhances the softness of GC main chain, which facilitates
polymer aggregation.[32] Consequently the CAC achieved
for the GCFA nanogel was significantly reduced to
0.0075mgmL1.3.3. Cell Viability
Chitosan and its derivatives are not significantly toxic,[33]
GC being one of the less toxic derivatives.[34] Further
GC modifications could improve or decrease the final
cytotoxicity. The effect of the nanogel on cell viability and
cell growth was gauged using RAW and HeLa cell lines
in a MTT assay. As shown in Figure 5A, the proliferation13, 13, 1369–1378
bH & Co. KGaA, Weinheim 1375
Figure 5. Effect of GC and GCFA nanogels (0.1 and 0.5mgmL1) on viability of A) HeLa
and B) RAW cells, measured by MTT assay. Cell culture medium was used as negative
control (RPMI-1640 to HeLa cells and DMEM to RAW cell line) and 20% of DMSO as
positive control. Twenty-five percent dH2O condition was also studied because each
nanogel sample in culture medium containing 25% of water v/v. Statistical differences
between negative control group (cell culture medium) and remaining samples at each
time of incubation are represented as () and (#) means the statistical differences
between 0h incubation time and remaining incubation times for each condition.
Significance degree (one, two, or three symbols) was chosen according to p values
(p<0.05, p<0.01, and p<0.0001, respectively).
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1376of HeLa cells was significantly affected in the presence of
the nanogels. However, cell growth was still observed.
Indeed, the treated cellswereable togrow, althoughwitha
lower rate thanobserved for the controls. TheRAWcell line
(Figure 5B) exhibited an even slower growth rate, but
the cell number never decreased below the initial value,
suggesting that cell viability is not compromised. Overall,
the presence of folate did not affect the cell viability,
in agreement with the observation by Qu et al.,[35] who
reported that folate moieties did not influence cell
cytotoxicity.3.4. Cellular Uptake
3.4.1. In Vitro Targeting Ability
Folate receptors are extensively expressed in several
kinds of tumor, including cervical cancer.[36] Hence,Macromol. Biosci. 2013, 13, 1369–1378
 2013 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheHeLa cells were used to assess the
targeting ability conferred by the
folate moiety grafted on the nanogel
surface. Cells treated with the nanogels
labeled with a fluorescent probe were
observed by confocal microscopy
(Figure 6A,B). Cells incubatedwith nano-
gel without ligand exhibited a fluores-
cent signal punctuated on the cell
surface and minimal fluorescence on
the cytoplasm, as shown in the amplified
insert image. Probably, in the absence
of targeting ligand and due to the
slightly positive surface charge, the
nanogel accumulates at the surface of
the cellular membrane. In contrast,
nanogel bearing folate provided signifi-
cant internalization, which suggests
that the enhancement of GCFA nanogel
uptake was due to folate receptor medi-
ated endocytosis (Figure 6C,D).3.4.2. BMDM Cellular Uptake
The interaction with the mononuclear
phagocyte system is crucial when a
carrier is conceived for systemic appli-
cation. In order to investigate whether
the nanogels are phagocytosed by mac-
rophages, fluorescent nanogels were
incubated with BMDM. Figure 7A–C
illustrates the cellular uptake of fluores-
cein isothiocyanate (FITC)-labeled dex-
trin nanogel (used as a positive control
of macrophages uptake, as shown byGonc¸alves et al.),[37] NHS-fluorescein labeled GC and
GCFA nanogels, respectively. Interestingly, the GC nano-
gel was poorly internalized by BMDM as compared with
dextrin nanoparticles. Sarmento et al.[38] also reported
that chitosan coated solid lipid nanoparticles were
neglectfully internalized within RAW 264.7 cells, as
compared with uncoated solid lipid nanoparticles. As
verified by Parveen and Sahoo[11] the PEG content
chosen (10%) was determinant on decreasing of
macrophage cellular uptake. Indubitably this is a
promising result since GC nanogel may thus evade
blood clearance and keep on circulation enough time to
find the target site. GCFA nanogel was also not internal-
ized by BMDM, hinting that this vehicle is a promising
vector for drug and gene delivery. The effectiveness of
the GCFA nanogel in escaping macrophage uptake is
probably due to the PEG, which avoids opsonization
and consequently increases the circulation time in the
bloodstream.[11,39]im www.MaterialsViews.com
Figure 6. Internalization of nanogels labeled with NHS-fluorescein by HeLa cells with
and without folate. A and B) Distribution pattern of non-functionalized nanogel and C
and D) nanogel with folate, after sixth hours of incubation. Images on the left
correspond to the sum of all captured plans, while images on the right side refer
just to the fourth plan, corresponding to an internal section of the cells, such that the
observed green fluorescence should correspond to material inside the cells, not surface
adsorbed.
Figure 7. Confocal microscopic images of BMDM treated with fluorescent labeled
A) dextrin nanogel, B) GC, and C) GCFA nanogels for 6 h.
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TheGCnanogel complexes siRNAthrough
electrostatic interactions.AsGCpossesses
amino groups with a pKa close to 6.5,
below this pH the amino groups are
protonated.[40,41] Accordingly, in order
to induce a stronger interaction between
negatively charged phosphate groups
fromsiRNAandpositively charged amino
groups from GC, we used a nanogel
solution in 0.2 M sodium acetate
buffer pH 4.5. A gel retardation assay
was used to evaluate the nanogel–siRNA
interaction. Figure 8 shows the gel-
retardation results obtained for different
amine (N)/phosphate (P) ratios. The use of
a N/P molar ratio of 10 resulted in a
delayed migration of the siRNA, as
compared to naked siRNA. However, the
electrophoretic mobility of siRNA was
retardedmore effectivelywith increasing
N/P ratio and complete retardation of
siRNA migration on agarose matrix was
observed for the higher N/P ratio. The
retention of siRNA in the loading well
suggests that, at this molar ratio, a tight
and stable interaction between nanogel
and siRNA occurs.4. Conclusion
A self-assembled nanogel made of
amphiphilic GC was successfully devel-
oped. Decoration with folate moiety
conferred the nanogel the ability to
improve the interaction with folate-
receptor expressing cells, supporting
its internalization through receptor-me-
diated endocytosis. The nanogels were
not cytotoxic for the tested cell lines,
although growth inhibition was ob-
served to some extent. GC nanogels
showed to be attractive for systemic
administration due to their ability to
escape from macrophages and conse-
quently elongate lifetime in circulation
until achieve the target site. GC nanogel
proved to be a promising gene carrier,
but, besides complexing siRNA efficient-
ly, could also load low-molecular-weight
hydrophobic drugs into the hydrophobic
core.heim 1377
Figure 8. Gel retardation assay of GC nanogel/siRNA complex.
Lane 1 is a 21 bp siRNA unknown sequence; lanes 2–4 are GC/siRNA
formulation with N/P molar ratio of 10, 50, and 100, respectively.
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